Skip to main content
. 2022 Dec 5;110(3):333–342. doi: 10.1093/bjs/znac388

Table 1.

Patient and treatment characteristics at baseline according to treatment received

SAP
(n =227)
TAP
(n =237)
Age (years), mean(s.d.) 48.8 (14.0) 48.9 (14.4)
Sex ratio (M : F) 72 : 155 81 : 156
BMI (kg/m2), mean(s.d.) 27.4 (5.0) 26.9 (4.8)
SFJ reflux present 195 (85.9) 219 (92.4)
Refluxing saphenous trunk
ȃGSV 145 (63.9) 147 (62.0)
ȃAASV 80 (35.2) 87 (36.7)
ȃMissing 2 (0.9) 3 (1.3)
VCSS at baseline, mean(s.d.) 6.0 (2.2) 5.9 (2.3)
C(EAP) class
ȃC2 66 (29.1) 66 (27.8)
ȃC3 94 (41.4) 108 (45.6)
ȃC4–6 57 (25.1) 54 (22.8)
ȃMissing 10 (4.4) 9 (3.8)
Total phlebectomy length (cm)
ȃ< 15 10 (4.4) 27 (11.4)
ȃ15–30 81 (35.7) 79 (33.3)
ȃ> 30 131 (57.7) 110 (46.4)
ȃMissing 5 (2.2) 21 (8.9)
Length of treated trunk (cm), mean(s.d.) 20.9 (10.7)
Energy used (J/cm), mean(s.d.) 60.6 (14.9)

Values are n (%), unless otherwise indicated. SAP, isolated ambulatory phlebectomy with or without delayed endovenous truncal ablation; TAP, thermal ablation with concomitant phlebectomy; SFJ, saphenofemoral junction; GSV, great saphenous vein; AASV, anterior accessory saphenous vein; VCSS, Venous Clinical Severity Score; CEAP, Clinical Etiologic Anatomic Pathophysiologic.